Kohji Noguchi

Tokyo, 1258585, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Allosteric targeting of the ACE2 dimer interface by a medium-sized compound inhibits SARS-CoV-2 entry.

Allosteric targeting of the ACE2 dimer interface by a medium-sized compound inhibits SARS-CoV-2 entry.

Journal: Journal of molecular biology

Published: February 11, 2026

Structural Insights into the SARS-CoV-2 Spike Protein and Its Implications for Antibody Resistance.

Structural Insights into the SARS-CoV-2 Spike Protein and Its Implications for Antibody Resistance.

Journal: Biomolecules

Published: September 08, 2025

The role of IL-4+ memory T cells in SARS-CoV-2 booster vaccination.

The role of IL-4+ memory T cells in SARS-CoV-2 booster vaccination.

Journal: International immunology

Published: June 23, 2025

Synergistic activation of bat SARS-like coronaviruses spike protein by elastase and TMPRSS2.

Synergistic activation of bat SARS-like coronaviruses spike protein by elastase and TMPRSS2.

Journal: Scientific reports

Published: March 21, 2025

Inhibition Mechanism of SARS-CoV-2 Infection by a Cholesterol Derivative, Nat-20(S)-yne.

Inhibition Mechanism of SARS-CoV-2 Infection by a Cholesterol Derivative, Nat-20(S)-yne.

Journal: Biological & pharmaceutical bulletin

Published: May 01, 2024

Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies.

Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies.

Journal: iScience

Published: October 27, 2023

The combination of levodopa with levodopa-metabolizing enzyme inhibitors prevents severe fever with thrombocytopenia syndrome virus infection in vitro more effectively than single levodopa.

The combination of levodopa with levodopa-metabolizing enzyme inhibitors prevents severe fever with thrombocytopenia syndrome virus infection in vitro more effectively than single levodopa.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: December 03, 2022

Direct Inhibition of SARS-CoV-2 Spike Protein by Peracetic Acid.

Direct Inhibition of SARS-CoV-2 Spike Protein by Peracetic Acid.

Journal: International journal of molecular sciences

Published: November 09, 2022

SARS-CoV-2 Spike Protein Mutation at Cysteine-488 Impairs Its Golgi Localization and Intracellular S1/S2 Processing.

SARS-CoV-2 Spike Protein Mutation at Cysteine-488 Impairs Its Golgi Localization and Intracellular S1/S2 Processing.

Journal: International journal of molecular sciences

Published: October 08, 2022

Kaposi's sarcoma-associated herpesvirus replication and transcription activator protein activates CD274/PD-L1 gene promoter.

Kaposi's sarcoma-associated herpesvirus replication and transcription activator protein activates CD274/PD-L1 gene promoter.

Journal: Cancer science

Published: August 08, 2022

The function of SARS-CoV-2 spike protein is impaired by disulfide-bond disruption with mutation at cysteine-488 and by thiol-reactive N-acetyl-cysteine and glutathione.

The function of SARS-CoV-2 spike protein is impaired by disulfide-bond disruption with mutation at cysteine-488 and by thiol-reactive N-acetyl-cysteine and glutathione.

Journal: Biochemical and biophysical research communications

Published: January 18, 2022

L-DOPA, a treatment for Parkinson's disease, and its enantiomer D-DOPA inhibit severe fever with thrombocytopenia syndrome virus infection in vitro.

L-DOPA, a treatment for Parkinson's disease, and its enantiomer D-DOPA inhibit severe fever with thrombocytopenia syndrome virus infection in vitro.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: August 21, 2021

Showing 1-12 of 34

Last Updated: 09/26/2026